.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective requires addition of clients along with MASLD and dimension of liver end results in cardio-- kidney-- metabolic trials, when information suggest mechanistically tenable benefits and clinical safety-- and describes points to consider for trial style as well as governing approval.